Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology

Hong Kong Liver Cancer (HKLC) staging system was developed for prognostic and treatment evaluation for hepatocellular carcinoma (HCC) but is not externally validated. We aimed to evaluate and compare HKLC system with Barcelona Clínic Liver Cancer (BCLC) staging system. The prognostic performance, di...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Su, Chien-Wei, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2015
Soggetti:
4500
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616786/
https://ncbi.nlm.nih.gov/pubmed/26469917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001772
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi